AAAAAA

   
Results: 1-25 | 26-42
Results: 1-25/42
MEASUREMENT OF SERUM TSH IN THE INVESTIGATION OF PATIENTS PRESENTING WITH THYROID ENLARGEMENT
Authors: LIM AKP DAYKIN J HOLDER R SHEPPARD MC FRANKLYN JA
Citation: Akp. Lim et al., MEASUREMENT OF SERUM TSH IN THE INVESTIGATION OF PATIENTS PRESENTING WITH THYROID ENLARGEMENT, QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS, 91(10), 1998, pp. 687-689
THE USE OF A NEURAL-NETWORK TO DETECT UPPER AIRWAY-OBSTRUCTION CAUSEDBY GOITER
Authors: BRIGHT P MILLER MR FRANKLYN JA SHEPPARD MC
Citation: P. Bright et al., THE USE OF A NEURAL-NETWORK TO DETECT UPPER AIRWAY-OBSTRUCTION CAUSEDBY GOITER, American journal of respiratory and critical care medicine, 157(6), 1998, pp. 1885-1891
LACK OF ASSOCIATION BETWEEN POLYMORPHISM OF THE THYROTROPIN RECEPTOR GENE AND GRAVES-DISEASE IN UNITED-KINGDOM AND HONG-KONG CHINESE PATIENTS - CASE-CONTROL AND FAMILY-BASED STUDIES
Authors: ALLAHABADIA A HEWARD JM MIJOVIC C CARRSMITH J DAYKIN J COCKRAM C BARNETT AH SHEPPARD MC FRANKLYN JA GOUGH SCL
Citation: A. Allahabadia et al., LACK OF ASSOCIATION BETWEEN POLYMORPHISM OF THE THYROTROPIN RECEPTOR GENE AND GRAVES-DISEASE IN UNITED-KINGDOM AND HONG-KONG CHINESE PATIENTS - CASE-CONTROL AND FAMILY-BASED STUDIES, Thyroid, 8(9), 1998, pp. 777-780
DIFFERENTIAL REGULATION OF THE HUMAN THYROTROPIN ALPHA-SUBUNIT PROMOTER BY THYROID-HORMONE RECEPTORS ALPHA-1 AND BETA-1
Authors: MCCABE CJ YARWOOD NJ GURR JA GITTOES NJ SHEPPARD MC FRANKLYN JA
Citation: Cj. Mccabe et al., DIFFERENTIAL REGULATION OF THE HUMAN THYROTROPIN ALPHA-SUBUNIT PROMOTER BY THYROID-HORMONE RECEPTORS ALPHA-1 AND BETA-1, Thyroid, 8(7), 1998, pp. 601-608
AN ABNORMALITY OF THYROID-HORMONE RECEPTOR EXPRESSION MAY EXPLAIN ABNORMAL THYROTROPIN PRODUCTION IN THYROTROPIN-SECRETING PITUITARY-TUMORS
Authors: GITTOES NJL MCCABE CJ VERHAEG J SHEPPARD MC FRANKLYN JA
Citation: Njl. Gittoes et al., AN ABNORMALITY OF THYROID-HORMONE RECEPTOR EXPRESSION MAY EXPLAIN ABNORMAL THYROTROPIN PRODUCTION IN THYROTROPIN-SECRETING PITUITARY-TUMORS, Thyroid, 8(1), 1998, pp. 9-14
FETAL THYROTROPIN - THE BEST INDICATOR OF LONG-TERM THYROID-FUNCTION AFTER IN-UTERO EXPOSURE TO I-131
Authors: WELCH CR HOCKING M FRANKLYN JA WHITTLE MJ
Citation: Cr. Welch et al., FETAL THYROTROPIN - THE BEST INDICATOR OF LONG-TERM THYROID-FUNCTION AFTER IN-UTERO EXPOSURE TO I-131, Fetal diagnosis and therapy, 13(3), 1998, pp. 176-178
NO EVIDENCE FOR ALLELIC ASSOCIATION OF A HUMAN CTLA-4 PROMOTER POLYMORPHISM WITH AUTOIMMUNE THYROID-DISEASE IN EITHER POPULATION-BASED CASE-CONTROL OR FAMILY-BASED STUDIES
Authors: HEWARD JM ALLAHABADIA A CARRSMITH J DAYKIN J COCKRAM CS GORDON C BARNETT AH FRANKLYN JA GOUGH SCL
Citation: Jm. Heward et al., NO EVIDENCE FOR ALLELIC ASSOCIATION OF A HUMAN CTLA-4 PROMOTER POLYMORPHISM WITH AUTOIMMUNE THYROID-DISEASE IN EITHER POPULATION-BASED CASE-CONTROL OR FAMILY-BASED STUDIES, Clinical endocrinology, 49(3), 1998, pp. 331-334
RETINOID-X-RECEPTOR EXPRESSION IN THE NORMAL PITUITARY AND CLINICALLYNONFUNCTIONING PITUITARY-TUMORS
Authors: GITTOES NJL MCCABE CJ VERHAEG J SHEPPARD MC FRANKLYN JA
Citation: Njl. Gittoes et al., RETINOID-X-RECEPTOR EXPRESSION IN THE NORMAL PITUITARY AND CLINICALLYNONFUNCTIONING PITUITARY-TUMORS, Clinical endocrinology, 48(4), 1998, pp. 425-433
RETINOID-X-RECEPTOR GAMMA MESSENGER-RNA EXPRESSION IS REDUCED IN RECURRENT NONFUNCTIONING PITUITARY-ADENOMAS
Authors: GITTOES NJL MCCABE CJ SHEPPARD MC FRANKLYN JA
Citation: Njl. Gittoes et al., RETINOID-X-RECEPTOR GAMMA MESSENGER-RNA EXPRESSION IS REDUCED IN RECURRENT NONFUNCTIONING PITUITARY-ADENOMAS, Clinical endocrinology, 48(4), 1998, pp. 527-527
MORTALITY AFTER THE TREATMENT OF HYPERTHYROIDISM WITH RADIOACTIVE IODINE
Authors: FRANKLYN JA MAISONNEUVE P SHEPPARD MC BETTERIDGE J BOYLE P
Citation: Ja. Franklyn et al., MORTALITY AFTER THE TREATMENT OF HYPERTHYROIDISM WITH RADIOACTIVE IODINE, The New England journal of medicine, 338(11), 1998, pp. 712-718
CIRCULATING THYROID-HORMONE CONCENTRATIONS AND PLACENTAL THYROID-HORMONE RECEPTOR EXPRESSION IN NORMAL HUMAN-PREGNANCY AND PREGNANCY COMPLICATED BY INTRAUTERINE GROWTH RESTRICTION (IUGR)
Authors: KILBY MD VERHAEG J GITTOES N SOMERSET DA CLARK PMS FRANKLYN JA
Citation: Md. Kilby et al., CIRCULATING THYROID-HORMONE CONCENTRATIONS AND PLACENTAL THYROID-HORMONE RECEPTOR EXPRESSION IN NORMAL HUMAN-PREGNANCY AND PREGNANCY COMPLICATED BY INTRAUTERINE GROWTH RESTRICTION (IUGR), The Journal of clinical endocrinology and metabolism, 83(8), 1998, pp. 2964-2971
FIBROBLAST-GROWTH-FACTOR-1 AND FIBROBLAST-GROWTH-FACTOR-2 AND FIBROBLAST-GROWTH-FACTOR-RECEPTOR-1 ARE ELEVATED IN THYROID HYPERPLASIA
Authors: THOMPSON SD FRANKLYN JA WATKINSON JC VERHAEG JM SHEPPARD MC EGGO MC
Citation: Sd. Thompson et al., FIBROBLAST-GROWTH-FACTOR-1 AND FIBROBLAST-GROWTH-FACTOR-2 AND FIBROBLAST-GROWTH-FACTOR-RECEPTOR-1 ARE ELEVATED IN THYROID HYPERPLASIA, The Journal of clinical endocrinology and metabolism, 83(4), 1998, pp. 1336-1341
LINKAGE DISEQUILIBRIUM BETWEEN THE HUMAN-LEUKOCYTE ANTIGEN CLASS-II REGION OF THE MAJOR HISTOCOMPATIBILITY COMPLEX AND GRAVES-DISEASE - REPLICATION USING A POPULATION CASE-CONTROL AND FAMILY-BASED STUDY
Authors: HEWARD JM ALLAHABADIA A DAYKIN J CARRSMITH J DALY A ARMITAGE M DODSON PM SHEPPARD MC BARNETT AH FRANKLYN JA GOUGH SCL
Citation: Jm. Heward et al., LINKAGE DISEQUILIBRIUM BETWEEN THE HUMAN-LEUKOCYTE ANTIGEN CLASS-II REGION OF THE MAJOR HISTOCOMPATIBILITY COMPLEX AND GRAVES-DISEASE - REPLICATION USING A POPULATION CASE-CONTROL AND FAMILY-BASED STUDY, The Journal of clinical endocrinology and metabolism, 83(10), 1998, pp. 3394-3397
HYPERTHYROIDISM - CURRENT TREATMENT GUIDELINES
Authors: GITTOES NJL FRANKLYN JA
Citation: Njl. Gittoes et Ja. Franklyn, HYPERTHYROIDISM - CURRENT TREATMENT GUIDELINES, Drugs, 55(4), 1998, pp. 543-553
MANAGEMENT GUIDELINES FOR HYPERTHYROIDISM
Authors: FRANKLYN JA
Citation: Ja. Franklyn, MANAGEMENT GUIDELINES FOR HYPERTHYROIDISM, Bailliere's clinical endocrinology and metabolism, 11(3), 1997, pp. 561-571
CONSENSUS STATEMENT FOR GOOD PRACTICE AND AUDIT MEASURES IN THE MANAGEMENT OF HYPOTHYROIDISM AND HYPERTHYROIDISM (REPRINTED)
Authors: VANDERPUMP MPJ AHLQUIST JAO FRANKLYN JA CLAYTON RN
Citation: Mpj. Vanderpump et al., CONSENSUS STATEMENT FOR GOOD PRACTICE AND AUDIT MEASURES IN THE MANAGEMENT OF HYPOTHYROIDISM AND HYPERTHYROIDISM (REPRINTED), Bailliere's clinical endocrinology and metabolism, 11(3), 1997, pp. 572-584
INFLAMMATORY CYTOKINES AND TYPE-I 5'-DEIODINASE EXPRESSION IN PHI(1) RAT-LIVER CELLS
Authors: DAVIES PH SHEPPARD MC FRANKLYN JA
Citation: Ph. Davies et al., INFLAMMATORY CYTOKINES AND TYPE-I 5'-DEIODINASE EXPRESSION IN PHI(1) RAT-LIVER CELLS, Molecular and cellular endocrinology, 129(2), 1997, pp. 191-198
TRANSFECTION OF CARDIAC-MUSCLE - EFFECTS OF OVEREXPRESSION OF C-MYC AND C-FOS PROTOONCOGENE PROTEINS IN PRIMARY CULTURES OF NEONATAL SAT CARDIAC MYOCYTES
Authors: GREEN NK FRANKLYN JA OHANIAN V HEAGERTY AM GAMMAGE MD
Citation: Nk. Green et al., TRANSFECTION OF CARDIAC-MUSCLE - EFFECTS OF OVEREXPRESSION OF C-MYC AND C-FOS PROTOONCOGENE PROTEINS IN PRIMARY CULTURES OF NEONATAL SAT CARDIAC MYOCYTES, Clinical science, 92(2), 1997, pp. 181-188
THYROID-HORMONE AND ESTROGEN-RECEPTOR EXPRESSION IN NORMAL PITUITARY AND NONFUNCTIONING TUMORS OF THE ANTERIOR-PITUITARY
Authors: GITTOES NJL MCCABE CJ VERHAEG J SHEPPARD MC FRANKLYN JA
Citation: Njl. Gittoes et al., THYROID-HORMONE AND ESTROGEN-RECEPTOR EXPRESSION IN NORMAL PITUITARY AND NONFUNCTIONING TUMORS OF THE ANTERIOR-PITUITARY, The Journal of clinical endocrinology and metabolism, 82(6), 1997, pp. 1960-1967
CARDIAC-HYPERTROPHY AS A RESULT OF LONG-TERM THYROXINE THERAPY AND THYROTOXICOSIS
Authors: CHING GW FRANKLYN JA STALLARD TJ DAYKIN J SHEPPARD MC GAMMAGE MD
Citation: Gw. Ching et al., CARDIAC-HYPERTROPHY AS A RESULT OF LONG-TERM THYROXINE THERAPY AND THYROTOXICOSIS, HEART, 75(4), 1996, pp. 363-368
REGULATION OF TYPE-I 5'-DEIODINASE BY THYROID-HORMONE AND DEXAMETHASONE IN RAT-LIVER AND KIDNEY-CELLS
Authors: DAVIES PH SHEPPARD MC FRANKLYN JA
Citation: Ph. Davies et al., REGULATION OF TYPE-I 5'-DEIODINASE BY THYROID-HORMONE AND DEXAMETHASONE IN RAT-LIVER AND KIDNEY-CELLS, Thyroid, 6(3), 1996, pp. 221-228
THYROID-DISEASE - EFFECTS ON CARDIOVASCULAR FUNCTION
Authors: FRANKLYN JA GAMMAGE MD
Citation: Ja. Franklyn et Md. Gammage, THYROID-DISEASE - EFFECTS ON CARDIOVASCULAR FUNCTION, Trends in endocrinology and metabolism, 7(2), 1996, pp. 50-54
CONSENSUS STATEMENT FOR GOOD PRACTICE AND AUDIT MEASURES IN THE MANAGEMENT OF HYPOTHYROIDISM AND HYPERTHYROIDISM
Authors: VANDERPUMP MPJ AHLQUIST JAO FRANKLYN JA CLAYTON RN
Citation: Mpj. Vanderpump et al., CONSENSUS STATEMENT FOR GOOD PRACTICE AND AUDIT MEASURES IN THE MANAGEMENT OF HYPOTHYROIDISM AND HYPERTHYROIDISM, BMJ. British medical journal, 313(7056), 1996, pp. 539-544
UPPER AIRWAYS OBSTRUCTION IN 153 CONSECUTIVE PATIENTS PRESENTING WITHTHYROID ENLARGEMENT
Authors: GITTOES NJL MILLER MR DAYKIN J SHEPPARD MC FRANKLYN JA
Citation: Njl. Gittoes et al., UPPER AIRWAYS OBSTRUCTION IN 153 CONSECUTIVE PATIENTS PRESENTING WITHTHYROID ENLARGEMENT, BMJ. British medical journal, 312(7029), 1996, pp. 484-484
MEMBRANE-SURFACE RECEPTORS - PREFACE
Authors: SHEPPARD MC FRANKLYN JA
Citation: Mc. Sheppard et Ja. Franklyn, MEMBRANE-SURFACE RECEPTORS - PREFACE, Bailliere's clinical endocrinology and metabolism, 10(1), 1996, pp. 9-9
Risultati: 1-25 | 26-42